Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B Kinder Challenge Dose in Adolescents Previously Vaccinated with Infanrix Hexa
NCT02052661Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Primary completion
- Sep 2014
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Primary endpoint: Anti-HBs Immune Response at 1 month. Started Feb 2014; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02052661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052661.